ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Reinvestment Rate
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Reinvestment Rate of 0.10x as of June 2026, reinvesting $13.74 Million (capex $10.30 Million plus investments $-3.44 Million) from operating cash flow of $134.76 Million. See ACAD cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ACADIA Pharmaceuticals Inc Cash Flow Reinvestment Rate (2023–2025)
Historical reinvestment intensity for ACADIA Pharmaceuticals Inc across 3 annual periods. For the full cash flow conversion analysis, see ACAD cash flow metrics.
Annual Cash Flow Reinvestment Rate for ACADIA Pharmaceuticals Inc (2023–2025)
Year-by-year capital reinvestment analysis for ACADIA Pharmaceuticals Inc. See ACADIA Pharmaceuticals Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.85x | $203.73 Million | $109.84 Million | $4.69 Million | ▲ +841.8% |
| 2024 | 0.20x | $31.06 Million | $157.72 Million | $523.00K | ▼ -95.4% |
| 2023 | 4.31x | $72.05 Million | $16.70 Million | $40.05 Million | — |